|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tue 04 |
|
Wed 05 |
|
Thu 06 |
|
Fri 07 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chair: Roy Shenhar (The Hebrew University of Jerusalem, Israel) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09:00-09:30 |
|
KEYNOTE |
|
Super-selective nanomedicines |
|
Giuseppe Battaglia,
University College London, UK |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
09:30-10:00 |
|
KEYNOTE |
|
Magnetic Nanocrystals and magnetic hyperthermia to tackle cancer |
|
Teresa Pellegrino,
IIT, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:00-10:15 |
|
|
Gold nanoparticles decorated Reduced Graphene Oxide electrodes for detection of a cancer biomarker candidate |
|
Chiara Ingrosso,
CNR-IPCF, Università degli Studi di Bari, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:15-10:30 |
|
|
An In vivo Study On Cobalt Ferrite Nanoparticles As Multi-Modal Cancer Therapy Combining Intrinsic Toxicity and Hyperthermia |
|
Preethi Bala Balakrishnan,
Istituto Italiano di Tecnologia, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:30-11:30 |
|
Coffee Break / Poster Session |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Chair: Teresa Pellegrino (IIT, Italy) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11:30-11:45 |
|
|
Implementation of 2pl 3d nanofeatured microscaffolds and optogenetics |
|
Barbara Spagnolo,
Istituto Italiano di Tecnologia @CBN, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11:45-12:00 |
|
|
Novel MNPs-based isolation approach looking for "the needle in the haystack" |
|
Giorgia Giovannini,
Istituto Italiano di Tecnologia, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:00-12:30 |
|
INVITED |
|
Multifunctional neural interfaces with micro- and nano-structured tapered optical fibers
|
|
Ferruccio Pisanello,
CBN-IIT, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
12:30-13:00 |
|
INVITED |
|
Soft polymeric nanoconstructs for vascular drug delivery and tissue depots
|
|
Annalisa Palange,
IIT, Italy |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
